Detalles de la búsqueda
1.
Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study.
J Clin Med
; 13(9)2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38731220
2.
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials.
Clin Cosmet Investig Dermatol
; 17: 829-842, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38616886
3.
An overview of new and emerging antibody therapies for moderate-severe atopic dermatitis in adults.
Expert Rev Clin Pharmacol
; 16(12): 1239-1248, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38054328
4.
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.
J Dermatolog Treat
; 34(1): 2246602, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580895
Resultados
1 -
4
de 4
1
Próxima >
>>